MI Sign Up for eTOC Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Molecular Interventions 7:133-137, (2007)
© American Society for Pharmacology and Experimental Therapeutics
10.1124/mi.7.3.4
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ma, Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ma, Q.

Viewpoint

Aryl Hydrocarbon Receptor Degradation-Promoting Factor (ADPF) and the Control of the Xenobiotic Response

Qiang Ma

Receptor Biology Laboratory, Toxicology and Molecular Biology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV 26505

SUMMARY

The study of xenobiotic metabolism has long been a core activity in pharmacology. The diverse chemical transformations of xenobiotics in vivo are elegant in themselves, depending as they do on a battery of enzymes that include the cytochomes P450 (CYPs), and their reaction mechanisms have been elucidated by a great many pioneering pharmacologists who helped to launch the discipline. Today, researchers are finding surprising and subtle intricacies in the molecular control that underpins the xenobiotic response. For example, the inducible expression of CYP-encoding genes above normal basal output is controlled by specialized xenobiotic activated receptors (XARs), which include the aryl hydrocarbon receptor (AhR). But because CYP activities can be double-edged, supporting a multiplicity of chemical transformations, their expression levels must be tightly regulated over time and biological space. Indeed, the kinetics of xenobiotic-induced CYP expression suggest multiple checks and balances at both transcriptional and post-translational levels. Recent research points to the regulated degradation of AhR as one aspect of control. A key participant in directing AhR degradation has been identified—the AhR degradation promoting factor (ADPF)—which appears to serve as an E3 ubiquitin ligase. The biological machinery that controls the xenobiotic response thus encompasses an elegance deep beneath the traditional recognition of CYPs as catalysts of xenobiotic degradation.




This article has been cited by other articles:


Home page
Mol. Interv.Home page
M. Miranda and A. Sorkin
Regulation of Receptors and Transporters by Ubiquitination: New Insights into Surprisingly Similar Mechanisms
Mol. Interv., June 1, 2007; 7(3): 157 - 167.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ASPET Journals Pharmacological Reviews Drug Metabolism and Disposition
Molecular Interventions Molecular Pharmacology J Pharmacology and Exp Therapeutics
Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.